PTAB Probes Authenticity Of Prior Art In Pain Treatment Case
The Patent Trial and Appeal Board appeared skeptical Thursday of a pharmaceutical company's argument during a post-grant review that prior art introduced to invalidate one of its pain treatment patents lacked...To view the full article, register now.
Already a subscriber? Click here to view full article